In a column interesting, thought-provoking, informative and a bit infuriating all at the same time, Jon Markman says Endo Pharmaceuticals, makers of Percocet, is a "go-to" stock for next year?
Why? Aging baby boomers, he says, and that, even if you have to pay out of pocket, you'll cough up.
No comments:
Post a Comment